News releases
-
Memantine-Chat, July 17th, 2004
-
Axura® (Memantine) Shows Benefits on Both Behavioral Disturbances and Activities of Daily Living in Patients with Moderate to Severe Alzheimer`s Disease
-
New Study Results Demonstrate Beneficial Effects of Axura® (Memantine) on Brain Activity in Patients with Mild to Moderate Alzheimer’s Disease
-
Memantine captures US market


